Featured Research

from universities, journals, and other organizations

Primary Care Doctors Miss Opportunities To Recommend Colon Cancer Screening

Date:
February 3, 2009
Source:
University of California - Davis - Health System
Summary:
While it is known that patients with few primary care doctor's office visits are less likely to receive colorectal cancer screening, new research indicates that even patients who see their physicians regularly also do not receive screening.

While it is known that patients with few primary care doctor's office visits are less likely to receive colorectal cancer screening, new research indicates that even patients who see their physicians regularly also do not receive screening.

The study, which appears in the February issue of Cancer Epidemiology Biomarkers and Prevention, was conducted by a team of researchers at UC Davis, the University of Washington and Group Health Cooperative in Seattle.

"Colorectal cancer screening is not on the primary care agenda as much as it should be," said lead author Joshua Fenton, assistant professor of family and community medicine at UC Davis. "Opportunities are being missed."

Fenton and his colleagues reviewed records of nearly 50,000 men and women aged 50 to 78 who were eligible for colorectal cancer screening in 2002 and 2003 and enrolled in Group Health Cooperative — a large, prepaid, nonprofit health plan that coordinates care and coverage in Washington state.

Most screening tests are ordered by primary care physicians, so the investigators were not surprised to find that patients with very few primary doctor's office visits received little or no colorectal cancer screening. The team was more surprised, however, to discover that more than half of patients with frequent primary care visits — four or more per year — also did not get screened.

"Merely encouraging people to see their doctors won't increase screening," said Fenton. "Screening saves lives. We have to do more to make sure that eligible patients are identified during primary care visits and counseled about options."

The study authors advocate a number of tested ways to increase the likelihood that colorectal cancer screening is recommended in primary care settings, including educational programs for patients and doctors, reminder systems, financial incentives and doctor's office visits dedicated to preventive care.

Fenton explained that the history of breast cancer screening, which also used to be underutilized, can serve as a model for colorectal cancer screening.

"Today, women know to ask for breast cancer screening and doctors are accustomed to recommending it. It's become part of standard practice. Hopefully, we'll also get to that point with colorectal cancer screening. It's more common throughout the nation than it was 10 years ago, but we've still got a long way to go," he said.

It is estimated that there were 148,810 people diagnosed with and 49,960 deaths from cancer of the colon and rectum in 2008. Screening for the disease contributes to reducing these numbers by leading to the early removal of polyps that could later become cancerous.

The study was supported by grants from the National Cancer Institute, the American Cancer Society and an HMO Cancer Research Network pilot grant. In addition to Fenton, study authors were Peter Franks of UC Davis; Robert Reid and Diana Buist of Group Health Cooperative; and Laura-Mae Baldwin and Joann Elmore of the University of Washington.


Story Source:

The above story is based on materials provided by University of California - Davis - Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Davis - Health System. "Primary Care Doctors Miss Opportunities To Recommend Colon Cancer Screening." ScienceDaily. ScienceDaily, 3 February 2009. <www.sciencedaily.com/releases/2009/02/090203130704.htm>.
University of California - Davis - Health System. (2009, February 3). Primary Care Doctors Miss Opportunities To Recommend Colon Cancer Screening. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/02/090203130704.htm
University of California - Davis - Health System. "Primary Care Doctors Miss Opportunities To Recommend Colon Cancer Screening." ScienceDaily. www.sciencedaily.com/releases/2009/02/090203130704.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins